Back to NBIX
OPPENHEIMER & CO INC NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$7.6M
Q3 2026
Peak value
$8.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $5.8M |
| Q4 2025 | $5.8M |
| Q1 2026 | $5.5M |
| Q2 2026 | $8.1M |
| Q3 2026 | $7.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.6M | 53.6K | — | — |
| Q2 2026 | $8.1M | 47.8K | — | — |
| Q1 2026 | $5.5M | 42.1K | — | — |
| Q4 2025 | $5.8M | 40.6K | — | — |
| Q3 2025 | $5.8M | 41.0K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M